Seer reported a 50% increase in revenue for the fourth quarter of 2022, driven by growth in consumable and instrument sales of the Proteograph Product Suite, service projects, and lease revenue. The company's gross margin was 50% for the quarter. They anticipate revenue growth in 2023.
Revenue increased by 50% compared to the same quarter in the previous year.
The Proteograph Product Suite performed exceptionally well with customers.
Product-related revenue was $3.2 million, including $1.7 million from related parties.
Gross margin reached 50% for the quarter.
Seer expects full year 2023 revenue to be in the range of $23 million to $25 million, representing growth of 48% - 61% over full year 2022.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance